Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score-Reference-Cited by-同舟云学术

Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score

Published:2015-10-15 Issue:2 Volume:11 Page:199-204
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Pastori Daniele,Farcomeni Alessio,Poli Daniela,Antonucci Emilia,Angelico Francesco,Del Ben Maria,Cangemi Roberto,Tanzilli Gaetano,Lip Gregory Yoke Hong,Pignatelli Pasquale,Violi Francesco

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11739-015-1326-1.pdf

Reference16 articles.

1. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke J Cereb Circ 22(8):983–988

2. Pastori D, Pignatelli P, Angelico F, Farcomeni A, Del Ben M, Vicario T, Bucci T, Raparelli V, Cangemi R, Tanzilli G, Lip GY, Violi F (2015) Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors. Chest 147(6):1644–1650. doi: 10.1378/chest.14-2414

3. Polimeni L, Perri L, Saliola M, Basili S, Violi F (2010) The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue. Intern Emerg Med 5(2):91–94. doi: 10.1007/s11739-010-0352-2

4. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M (2014) Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 174(1):107–114. doi: 10.1001/jamainternmed.2013.11912

5. Soliman EZ, Lopez F, O’Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, Cushman M, Alonso A (2015) Atrial fibrillation and risk of st-segment-elevation versus non-ST-segment-elevation myocardial infarction: the atherosclerosis risk in communities (ARIC) study. Circulation 131(21):1843–1850. doi: 10.1161/CIRCULATIONAHA.114.014145

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simple scores to predict 1-year mortality in atrial fibrillation;Journal of Cardiovascular Medicine;2024-03-01

2. Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry;European Journal of Internal Medicine;2024-01

3. Factors associated with disease progression in patients with atrial fibrillation and heart failure anticoagulated with rivaroxaban;Clinical Cardiology;2023-11-29

4. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment;The American Journal of Cardiology;2023-09

5. Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry;Journal of Thrombosis and Thrombolysis;2023-08-11